Mental health is a vital aspect of overall well-being, especially for students who face unique pressures and challenges. From ...

The FDA added a warning to the label of esketamine nasal spray (Spravato), noting that long-term cognitive and memory ...

Learn more about how an anesthetic traditionally used for surgical procedures may help depression and what to expect during ...

When Dr. Husseini Manji was developing the first-in-class depression medication Spravato at Johnson & Johnson he encountered plenty of naysayers.

Expert analyst Patrick Trucchio has spent many years researching the psychedelic drug stock sector. Patrick Trucchio, CFA, is a Managing Director of Equity Research at H.C. Wainwright & Co. whose ...

Research presented at this year's Psych Congress meeting in Boston included a randomized trial of esketamine (Spravato) ...

"This data gives patients the option to benefit from esketamine treatment either with or without an antidepressant," said ...

Following esketamine for TRD, PHQ-9 scores significantly reduced by 5.9 in the overall cohort and 6.0 in the TMS-naïve subgroup. Sustained use of esketamine nasal spray significantly improves ...

Brain and Cognition Discovery Foundation, Toronto, ON, Canada Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, ON, Canada Department of Pharmacology & Toxicology, University ...

Initial studies demonstrating rapid antidepressant effects drove research leading to the recent US Food and Drug Administration (FDA) approval of intranasal esketamine, the first (and at present, only ...